The total return over the past 12 months is -0.39% vs. +16.94% for the S&P 500. So far it's up -73.04% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (0.39%) | +39.91% | +15.17% | (13.84%) | (21.78%) | N/A |
| Total Return CAGR | (0.39%) | +39.91% | +15.17% | (13.84%) | (21.78%) | N/A |
| Revenue CAGR | (100.00%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Capricor Therapeutics, Inc. (CAPR)
| Year | Start price | End price | CAPR Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $28.86 | $7.78 | (73.04%) | +14.51% | (87.55%) |
| 2025 | $13.80 | $28.86 | +109.13% | +17.72% | +91.41% |
| 2024 | $4.89 | $13.80 | +182.21% | +24.89% | +157.32% |
| 2023 | $3.86 | $4.89 | +26.68% | +26.19% | +0.49% |
| 2022 | $2.93 | $3.86 | +31.74% | (18.17%) | +49.91% |
| 2021 | $3.43 | $2.93 | (14.58%) | +28.74% | (43.32%) |
| 2020 | $1.28 | $3.43 | +167.97% | +18.37% | +149.60% |
| 2019 | $4.10 | $1.28 | (68.78%) | +31.22% | (100.00%) |
| 2018 | $15.80 | $4.10 | (74.05%) | (4.56%) | (69.49%) |
| 2017 | $26.60 | $15.80 | (40.60%) | +21.70% | (62.30%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
